ConductScience.org, home

Paper9640486

Mibefradil: a new class of calcium-channel antagonists.

Billups SJ and 1 other. Ann Pharmacother, 1998. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Mibefradil: a new class of calcium-channel antagonists. Papers, record 9640486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9640486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mibefradil: a new class of calcium-channel antagonists.
PubMed
Journal
Ann Pharmacother
PubMed
Year
1998
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2017-02-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Billups SJS J
2Carter BLB L

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angina PectorisMajor topic
BenzimidazolesMajor topic
Calcium Channel BlockersMajor topic
HypertensionMajor topic
TetrahydronaphthalenesMajor topic
Aged
Clinical Trials as Topic
Drug Interactions
Drug Therapy, Combination
Female
Humans
Male
Mibefradil

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in9876826Comment: mibefradil, a new class of calcium-channel antagonists.https://conductscience.org/library/papers/9876826

Source PubMed

Download CSV of comments and corrections

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
36766802Voltage-Gated T-Type Calcium Channel Modulation by Kinases and Phosphatases: The Old Ones, the New Ones, and the Missing Ones.Cells2023https://conductscience.org/library/papers/36766802PubMed
35002414Synthesis, characterization and in vitro, in vivo, in silico biological evaluations of substituted benzimidazole derivatives.Saudi J Biol Sci2022https://conductscience.org/library/papers/35002414PubMed
33723999Chemical Aspects of Human and Environmental Overload with Fluorine.Chem Rev2021https://conductscience.org/library/papers/33723999PubMed
24890831Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.Cold Spring Harb Perspect Med2014https://conductscience.org/library/papers/24890831PubMed
21817045Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.Science2011https://conductscience.org/library/papers/21817045PubMed
15000520Low-voltage-activated ("T-Type") calcium channels in review.J Bioenerg Biomembr2003https://conductscience.org/library/papers/15000520PubMed
10668858Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.Clin Pharmacokinet2000https://conductscience.org/library/papers/10668858PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9640486

GET https://conductscience.org/api/papers/v1/9640486/authors